Del laboratorio a la clínica en el ictus isquémico agudo. Modelos experimentales in vitro e in vivo

INTRODUCTION. Cerebrovascular disease is one of the leading causes of death, disability and dementia around the world. For the most common form of the disease, ischaemic stroke, there is only one drug available, tissue plasminogen activator, and few patients can benefit from this therapy because of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradillo, Jesús M., García-Culebras, Alicia, Cuartero, M. Isabel, Peña-Martínez, Carolina, Moro, M. Ángeles, Lizasoain, Ignacio, Moraga, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Viguera Editores (Evidenze Group) 2022
Materias:
Revisión
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280710/
https://www.ncbi.nlm.nih.gov/pubmed/36285448
http://dx.doi.org/10.33588/rn.7509.2022268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280710/
https://www.ncbi.nlm.nih.gov/pubmed/36285448
http://dx.doi.org/10.33588/rn.7509.2022268

Ejemplares similares